Analog Devices (ADI) 10-Q 17 Feb 21 2021 Q1 Quarterly report Financial data

Cover

Cover	3 Months Ended
	Jan. 30, 2021shares
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jan. 30, 2021
Document Transition Report	false
Entity File Number	1-7819
Entity Registrant Name	Analog Devices, Inc.
Entity Incorporation, State or Country Code	MA
Entity Tax Identification Number	04-2348234
Entity Address, Address Line One	One Analog Way,
Entity Address, City or Town	Wilmington,
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01887
City Area Code	781
Local Phone Number	329-4700
Title of 12(b) Security	Common Stock $0.16 2/3 par value per share
Entity Trading Symbol	ADI
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	368,893,742
Entity Central Index Key	0000006281
Current Fiscal Year End Date	--10-20
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Jan. 30, 2021	Feb. 01, 2020
Income Statement [Abstract]
Revenue	$ 1,558,458	$ 1,303,565
Cost of sales	513,087	455,423
Gross margin	1,045,371	848,142
Operating expenses:
Research and development	288,150	257,073
Selling, marketing, general and administrative	185,275	199,280
Amortization of intangibles	107,648	107,225
Special charges	438	11,136
Total operating expenses	581,511	574,714
Operating income:	463,860	273,428
Nonoperating expense (income):
Interest expense	42,479	48,813
Interest income	(209)	(1,940)
Other, net	(15,028)	338
Nonoperating expense (income)	27,242	47,211
Income before income taxes	436,618	226,217
Provision for income taxes	48,099	22,343
Net income	$ 388,519	$ 203,874
Shares used to compute earnings per common share – basic (in shares)	369,203	368,241
Shares used to compute earnings per common share – diluted (in shares)	373,106	372,264
Basic earnings per common share (in dollars per share)	$ 1.05	$ 0.55
Diluted earnings per common share (in dollars per share)	$ 1.04	$ 0.55

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Jan. 30, 2021	Feb. 01, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 388,519	$ 203,874
Foreign currency translation adjustments	8,279	(195)
Change in fair value of derivative instruments designated as cash flow hedges (net of taxes of $6,661 and $5,459, respectively)	24,465	(12,028)
Changes in pension plans including transition obligation, net actuarial loss and foreign currency translation adjustments (net of taxes of $86 and $160, respectively)	(1,784)	254
Other comprehensive income (loss)	30,960	(11,969)
Comprehensive income	$ 419,479	$ 191,905

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Jan. 30, 2021	Feb. 01, 2020
Statement of Comprehensive Income [Abstract]
Tax effect of change in fair value of derivative instruments designated as cash flow hedges	$ 6,661	$ 5,459
Tax effect of changes in pension plans including transition obligation, net actuarial loss and foreign currency translation adjustments	$ 86	$ 160

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 30, 2021	Oct. 31, 2020
Current Assets
Cash and cash equivalents	$ 1,048,063	$ 1,055,860
Accounts receivable	826,964	737,536
Inventories	618,640	608,260
Prepaid expenses and other current assets	131,074	116,032
Total current assets	2,624,741	2,517,688
Property, Plant and Equipment, at Cost
Land and buildings	981,717	974,604
Machinery and equipment	2,713,926	2,667,846
Office equipment	89,267	85,291
Leasehold improvements	160,034	157,915
Property, Plant and Equipment, at Cost	3,944,944	3,885,656
Less accumulated depreciation and amortization	2,815,730	2,765,095
Net property, plant and equipment	1,129,214	1,120,561
Other Assets
Other investments	91,720	86,729
Goodwill	12,282,751	12,278,425
Intangible assets, net	3,535,475	3,650,280
Deferred tax assets	1,466,489	1,503,064
Other assets	309,720	311,856
Total other assets	17,686,155	17,830,354
Total assets	21,440,110	21,468,603
Current Liabilities
Accounts payable	227,423	227,273
Income taxes payable	148,191	182,080
Debt, current	399,220	0
Accrued liabilities	901,923	955,633
Total current liabilities	1,676,757	1,364,986
Non-current liabilities
Long-term debt	4,747,347	5,145,102
Deferred income taxes	1,862,068	1,919,595
Income taxes payable	592,281	591,780
Other non-current liabilities	473,911	449,195
Total non-current liabilities	7,675,607	8,105,672
Commitments and contingencies	0	0
Shareholders’ Equity
Preferred stock, $1.00 par value, 471,934 shares authorized, none outstanding	0	0
Common stock, 0.16 2/3 par value, 1,200,000,000 shares authorized, 368,893,742 shares outstanding (369,484,899 on October 31, 2020)	61,484	61,582
Capital in excess of par value	4,849,185	4,949,586
Retained earnings	7,395,578	7,236,238
Accumulated other comprehensive loss	(218,501)	(249,461)
Total shareholders’ equity	12,087,746	11,997,945
Liabilities and Shareholders' Equity	$ 21,440,110	$ 21,468,603

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jan. 30, 2021	Oct. 31, 2020
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred stock, shares authorized (in shares)	471,934	471,934
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.16	$ 0.16
Common stock, shares authorized (in shares)	1,200,000,000	1,200,000,000
Common stock, shares outstanding (in shares)	368,893,742	369,484,899

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Capital in Excess of Par Value	Retained Earnings	Retained EarningsCumulative effect, period of adoption, adjustment	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive LossCumulative effect, period of adoption, adjustment
Beginning balance (in shares) at Nov. 02, 2019		368,302
Beginning balance at Nov. 02, 2019		$ 61,385	$ 4,936,349	$ 6,899,253	$ 2,379	$ (187,799)	$ (2,379)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 203,874			203,874
Dividends declared and paid				(199,160)
Issuance of stock as charitable contribution (in shares)		336
Issuance of stock as charitable contribution		$ 56	39,944
Issuance of stock under stock plans and other (in shares)		491
Issuance of stock under stock plans and other		$ 82	16,031
Stock-based compensation expense			37,501
Other comprehensive income (loss)	$ (11,969)					(11,969)
Common stock repurchased (in shares)		(909)
Common stock repurchased		$ (152)	(105,878)
Ending balance (in shares) at Feb. 01, 2020		368,220
Ending balance at Feb. 01, 2020		$ 61,371	4,923,947	6,906,346		(202,147)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting standards update [extensible list]	us-gaap:AccountingStandardsUpdate201802Member
Beginning balance (in shares) at Oct. 31, 2020		369,485
Beginning balance at Oct. 31, 2020	$ 11,997,945	$ 61,582	4,949,586	7,236,238		(249,461)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	388,519			388,519
Dividends declared and paid				(229,179)
Issuance of stock under stock plans and other (in shares)		488
Issuance of stock under stock plans and other		$ 82	19,838
Stock-based compensation expense			36,638
Other comprehensive income (loss)	30,960					30,960
Common stock repurchased (in shares)		(1,079)
Common stock repurchased		$ (180)	(156,877)
Ending balance (in shares) at Jan. 30, 2021		368,894
Ending balance at Jan. 30, 2021	$ 12,087,746	$ 61,484	$ 4,849,185	$ 7,395,578		$ (218,501)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting standards update [extensible list]	us-gaap:AccountingStandardsUpdate201802Member

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Jan. 30, 2021	Feb. 01, 2020
Statement of Stockholders' Equity [Abstract]
Dividends (in dollars per share)	$ 0.62	$ 0.54

Condensed Consolidated Statem_6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Jan. 30, 2021	Feb. 01, 2020
Cash flows from operating activities:
Net income	$ 388,519	$ 203,874
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	56,309	59,863
Amortization of intangibles	145,044	144,069
Stock-based compensation expense	36,638	37,501
Deferred income taxes	(27,275)	(13,982)
Non-cash contribution to charitable foundation	0	40,000
Other non-cash activity	(14,553)	2,332
Changes in operating assets and liabilities	(156,741)	(124,009)
Total adjustments	39,422	145,774
Net cash provided by operating activities	427,941	349,648
Cash flows from investing activities:
Proceeds from other investments	18,566	0
Additions to property, plant and equipment	(67,388)	(54,839)
Cash paid for asset acquisition	(22,522)	0
Payments for acquisitions, net of cash acquired	(2,428)	0
Changes in other assets	(1,299)	107
Net cash used for investing activities	(75,071)	(54,732)
Cash flows from financing activities:
Dividend payments to shareholders	(229,179)	(199,160)
Repurchase of common stock	(157,057)	(106,030)
Proceeds from employee stock plans	19,920	16,113
Changes in other financing activities	2,493	(495)
Net cash used for financing activities	(363,823)	(289,572)
Effect of exchange rate changes on cash	3,156	742
Net (decrease) increase in cash and cash equivalents	(7,797)	6,086
Cash and cash equivalents at beginning of period	1,055,860	648,322
Cash and cash equivalents at end of period	$ 1,048,063	$ 654,408

Basis of Presentation

Basis of Presentation	3 Months Ended
	Jan. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation In the opinion of management, the information furnished in the accompanying condensed consolidated financial statements reflects all normal recurring adjustments that are necessary to fairly state the results for these interim periods and should be read in conjunction with Analog Devices, Inc.’s (the Company) Annual Report on Form 10-K for the fiscal year ended October 31, 2020 (fiscal 2020) and related notes. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for the fiscal year ending October 30, 2021 (fiscal 2021) or any future period. The Company has a 52-53 week fiscal year that ends on the Saturday closest to the last day in October. Certain amounts reported in previous periods have been reclassified to conform to the fiscal 2021 presentation. Proposed acquisition of Maxim Integrated Products, Inc. On July 12, 2020, the Company entered into a definitive agreement (the Merger Agreement) to acquire Maxim Integrated Products, Inc. (Maxim), an independent manufacturer of innovative analog and mixed-signal products and technologies. See Note 13, Acquisitions , for additional information.

Stock-Based Compensation and Sh

Stock-Based Compensation and Shareholders' Equity	3 Months Ended
	Jan. 30, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation and Shareholders' Equity	Stock-Based Compensation and Shareholders' Equity A summary of the Company’s stock option activity as of January 30, 2021 and changes during the three-month period then ended is presented below: Options Outstanding (in thousands) Weighted- Average Exercise Price Per Share Weighted- Average Remaining Contractual Term in Years Aggregate Intrinsic Value Options outstanding at October 31, 2020 4,192 $70.73 Options granted 460 $144.06 Options exercised (349) $56.94 Options forfeited (21) $85.53 Options expired (5) $37.52 Options outstanding at January 30, 2021 4,277 $79.71 5.9 $289,219 Options exercisable at January 30, 2021 2,332 $61.96 4.4 $199,072 Options vested or expected to vest at January 30, 2021 (1) 4,158 $78.63 5.9 $285,622 (1) In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. The number of options expected to vest is calculated by applying an estimated forfeiture rate to the unvested options. In the first quarter of fiscal 2021, the Company issued a special performance stock option award to the Company's chief executive officer. The performance stock option award is exercisable for up to 460,000 shares of the Company's common stock (the Target Number of Shares) at an exercise price per share of $144.06, which was the closing price of the Company's common stock on the date of grant, and vests subject to the satisfaction of certain target stock price thresholds during a five five During the three-month periods ended January 30, 2021 and February 1, 2020, the total intrinsic value of options exercised (i.e., the difference between the market price at exercise and the price paid by the employee to exercise the options) was $30.4 million and $20.3 million, respectively. A summary of the Company’s restricted stock unit/award activity as of January 30, 2021 and changes during the three-month period then ended is presented below: Restricted Stock Units/Awards Outstanding (in thousands) Weighted- Average Grant- Date Fair Value Per Share Restricted stock units/awards outstanding at October 31, 2020 3,637 $91.54 Units/Awards granted 196 $138.21 Restrictions lapsed (135) $86.08 Forfeited (59) $99.73 Restricted stock units/awards outstanding at January 30, 2021 3,639 $92.02 In the first quarter of fiscal 2021, the Company issued approximately 110,000 performance-based restricted stock units (Maxim Integration PRSUs) related to the Company's planned acquisition of Maxim to a select group of employees. The number of Maxim Integration PRSUs that may be earned will range from 0% to a maximum of 200% of the issued amount of Maxim Integration PRSUs and will be determined according to the achievement of certain performance metrics. Any shares earned will vest on the 60th day following the two As of January 30, 2021, there was $267.1 million of total unrecognized compensation cost related to unvested stock-based awards comprised of stock options and restricted stock units/awards. That cost is expected to be recognized over a weighted-average period of 1.3 years. The total grant-date fair values of awards that vested during the three-month periods ended January 30, 2021 and February 1, 2020 were approximately $15.6 million and $14.8 million, respectively. Total stock-based compensation expense recognized was as follows: Three Months Ended January 30, 2021 February 1, 2020 Cost of sales $ 4,354 $ 4,564 Research and development 18,321 17,605 Selling, marketing, general and administrative 13,963 15,332 Total stock-based compensation expense $ 36,638 $ 37,501 As of January 30, 2021 and October 31, 2020, the Company capitalized $5.7 million and $5.8 million, respectively, of stock-based compensation in Inventories on the Condensed Consolidated Balance Sheets. Common Stock Repurchases As of January 30, 2021, the Company had repurchased a total of approximately 157.1 million shares of its common stock for approximately $6.4 billion under the Company's share repurchase program. As of January 30, 2021, an additional $1.7 billion remains available for repurchase of shares under the current authorized program. The Company also repurchases shares in settlement of employee tax withholding obligations due upon the vesting of restricted stock units/awards or the exercise of stock options. Future repurchases of common stock will be dependent upon the Company's financial position, results of operations, outlook, liquidity, and other factors deemed relevant by the Company.

Accumulated Other Comprehensive

Accumulated Other Comprehensive (Loss) Income	3 Months Ended
	Jan. 30, 2021
Equity [Abstract]
Accumulated Other Comprehensive (Loss) Income	Accumulated Other Comprehensive (Loss) Income The following table provides the changes in accumulated other comprehensive (loss) income (AOCI) by component and the related tax effects during the first three months of fiscal 2021. Foreign currency translation adjustment Unrealized holding gains (losses) on derivatives Pension plans Total October 31, 2020 $ (26,852) $ (172,670) $ (49,939) $ (249,461) Other comprehensive income (loss) before reclassifications 8,279 34,930 (2,446) 40,763 Amounts reclassified out of other comprehensive income (loss) — (3,804) 748 (3,056) Tax effects — (6,661) (86) (6,747) Other comprehensive income (loss) 8,279 24,465 (1,784) 30,960 January 30, 2021 $ (18,573) $ (148,205) $ (51,723) $ (218,501) The amounts reclassified out of AOCI into the Condensed Consolidated Statements of Income and the Condensed Consolidated Statements of Shareholders' Equity with presentation location during each period were as follows: Three Months Ended Comprehensive Income Component January 30, 2021 February 1, 2020 Location Unrealized holding losses (gains) on derivatives Currency forwards $ (1,986) $ (80) Cost of sales (1,064) 378 Research and development (1,218) 532 Selling, marketing, general and administrative Interest rate derivatives 464 464 Interest expense (3,804) 1,294 Total before tax 204 (370) Tax Effect of Accounting Standards Update 2018-02 — (2,379) Retained earnings $ (3,600) $ (1,455) Net of tax Amortization of pension components included in the computation of net periodic pension cost Actuarial losses 748 648 (86) (160) Tax $ 662 $ 488 Net of tax Total amounts reclassified out of AOCI, net of tax $ (2,938) $ (967) Realized gains or losses on investments are determined based on the specific identification basis and are recognized in nonoperating expense (income). There were no material net realized gains or losses from the sales of available-for-sale investments during any of the fiscal periods presented.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Jan. 30, 2021
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended January 30, 2021 February 1, 2020 Net Income $ 388,519 $ 203,874 Basic shares: Weighted-average shares outstanding 369,203 368,241 Earnings per common share basic: $ 1.05 $ 0.55 Diluted shares: Weighted-average shares outstanding 369,203 368,241 Assumed exercise of common stock equivalents 3,903 4,023 Weighted-average common and common equivalent shares 373,106 372,264 Earnings per common share diluted: $ 1.04 $ 0.55 Anti-dilutive shares related to: Outstanding stock-based awards 239 397

Special Charges

Special Charges	3 Months Ended
	Jan. 30, 2021
Restructuring and Related Activities [Abstract]
Special Charges	Special Charges The following table is a quarterly roll-forward from October 31, 2020 to January 30, 2021 of the employee separation and exit cost accruals established related to existing restructuring actions: Accrued Restructuring Closure of Manufacturing Facilities Repositioning Action Other Actions Balance at October 31, 2020 $ 45,176 $ 20,774 $ 3,489 First quarter fiscal 2021 special charges 438 — — Severance and other payments (1,950) (8,128) (333) Effect of foreign currency on accrual — 248 — Balance at January 30, 2021 $ 43,664 $ 12,894 $ 3,156 Current - accrued liabilities $ 33,433 $ 12,894 $ 3,156 Other non-current liabilities $ 10,231 $ — $ — Repositioning Action The Company recorded special charges of $137.5 million on a cumulative basis through January 30, 2021, as a result of organizational initiatives to better align the global workforce with the Company's long-term strategic plan. Approximately $123.3 million of the total charges was for severance and fringe benefit costs in accordance with either the Company's ongoing benefit plan or statutory requirements for the impacted manufacturing, engineering and selling, marketing, general and administrative (SMG&A) employees. The remaining $14.2 million of the charges were recorded in fiscal 2019 and related to the write-off of acquired intellectual property due to the Company's decision to discontinue certain product development strategies. Closure of Manufacturing Facilities

Property, Plant and Equipment

Property, Plant and Equipment	3 Months Ended
	Jan. 30, 2021
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant and Equipment As discussed in Note 5, Special Charges , the Company is planning to transition testing operations currently handled in its Singapore facility to its facilities in Penang, Malaysia and the Philippines, in addition to its outsourced assembly and test partners. Accordingly, management has entered into an agreement to sell the facility in Singapore in May 2021 and has determined that this facility and certain equipment therein have met the held for sale criteria as specified in ASC 360. No write-down to fair value was required upon this designation during fiscal 2020, as the fair value of the asset group, less costs to sell, was greater than its carrying value. As shown below, this carrying value was reclassified from various line items within Property, plant and equipment to Prepaid expenses and other current assets upon designation and remains in Prepaid expenses and other current assets as of January 30, 2021. Land and buildings $ 36,451 Machinery and equipment 1,468 Office equipment 197 Leasehold improvements 5,744 43,860 Less accumulated depreciation and amortization (21,706) Net property, plant and equipment reclassified to Prepaid expenses and other current assets $ 22,154

Segment Information

Segment Information	3 Months Ended
	Jan. 30, 2021
Segment Reporting [Abstract]
Segment Information	Segment Information The Company designs, develops, manufactures and markets a broad range of integrated circuits. The Company operates and tracks its results in one reportable segment based on the aggregation of eight operating segments . Revenue Trends by End Market The following table summarizes revenue by end market. The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the “sold to” customer information, the “ship to” customer information and the end customer product or application into which the Company’s product will be incorporated. As data systems for capturing and tracking this data and the Company's methodology evolves and improves, the categorization of products by end market can vary over time. When this occurs, the Company reclassifies revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of results within, each end market. Three Months Ended January 30, 2021 February 1, 2020 Revenue % of Revenue* Y/Y% Revenue % of Revenue* Industrial $ 855,454 55 % 24 % $ 687,685 53 % Communications 281,049 18 % 16 % 241,804 19 % Automotive 245,250 16 % 19 % 205,712 16 % Consumer 176,705 11 % 5 % 168,364 13 % Total revenue $ 1,558,458 100 % 20 % $ 1,303,565 100 % * The sum of the individual percentages may not equal the total due to rounding. Revenue by Sales Channel The following table summarizes revenue by channel. The Company sells its products globally through a direct sales force, third party distributors, independent sales representatives and via its website. Distributors are customers that buy products with the intention of reselling them. Direct customers are non-distributor customers and consist primarily of original equipment manufacturers (OEMs). Other customers include the U.S. government, government prime contractors and certain commercial customers for which revenue is recorded over time. Three Months Ended January 30, 2021 February 1, 2020 Channel Revenue % of Revenue* Revenue % of Revenue* Distributors $ 946,386 61 % $ 747,561 57 % Direct customers 589,456 38 % 529,731 41 % Other 22,616 1 % 26,273 2 % Total revenue $ 1,558,458 100 % $ 1,303,565 100 % * The sum of the individual percentages may not equal the total due to rounding.

Fair Value

Fair Value	3 Months Ended
	Jan. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value	Fair Value The Company defines fair value as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Level 1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 — Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability. Level 3 — Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. The tables below, set forth by level, presents the Company’s financial assets and liabilities, excluding accrued interest components that were accounted for at fair value on a recurring basis as of January 30, 2021 and October 31, 2020. The tables exclude cash on hand and assets and liabilities that are measured at historical cost or any basis other than fair value. As of January 30, 2021 and October 31, 2020, the Company held $205.7 million and $239.6 million, respectively, of cash and held-to-maturity investments that were excluded from the tables below. January 30, 2021 Fair Value measurement at Reporting Date using: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Total Assets Cash equivalents: Available-for-sale: Government and institutional money market funds $ 822,348 $ — $ 822,348 Corporate obligations (1) — 19,998 19,998 Other assets: Deferred compensation investments 59,490 — 59,490 Forward foreign currency exchange contracts (2) — 7,386 7,386 Total assets measured at fair value $ 881,838 $ 27,384 $ 909,222 Liabilities Interest rate derivatives $ — $ 185,349 $ 185,349 Total liabilities measured at fair value $ — $ 185,349 $ 185,349 (1) The amortized cost of the Company’s investments classified as available-for-sale as of January 30, 2021 was $20.0 million. (2) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 9, Derivatives, in these Notes to Condensed Consolidated Financial Statements for more information related to the Company's master netting arrangements. October 31, 2020 Fair Value measurement at Reporting Date using: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Total Assets Cash equivalents: Available-for-sale: Government and institutional money market funds $ 816,253 $ — $ 816,253 Other assets: Forward foreign currency exchange contracts (1) — 5,427 5,427 Deferred compensation investments 52,956 — 52,956 Total assets measured at fair value $ 869,209 $ 5,427 $ 874,636 Liabilities Interest rate derivatives $ — $ 214,586 $ 214,586 Total liabilities measured at fair value $ — $ 214,586 $ 214,586 (1) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 9, Derivatives, in these Notes to Condensed Consolidated Financial Statements for more information related to the Company's master netting arrangements. The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments: Cash equivalents — These investments are adjusted to fair value based on quoted market prices or are determined using a yield curve model based on current market rates. Deferred compensation plan investments — The fair value of these mutual fund, money market fund and equity investments are based on quoted market prices. Interest rate derivatives — The fair value of the interest rate derivatives is estimated using a discounted cash flow analysis based on the contractual terms of the derivative. Forward foreign currency exchange contracts — The estimated fair value of forward foreign currency exchange contracts, which includes derivatives that are accounted for as cash flow hedges and those that are not designated as cash flow hedges, is based on the estimated amount the Company would receive if it sold these agreements at the reporting date taking into consideration current interest rates as well as the creditworthiness of the counterparty for assets and the Company’s creditworthiness for liabilities. The fair value of these instruments is based upon valuation models using current market information such as strike price, spot rate, maturity date and volatility. Financial Instruments Not Recorded at Fair Value on a Recurring Basis Held for sale assets — The Company has classified the assets held for sale at carrying value. However, if they were to be carried at fair value, they would be considered a Level 3 fair value measurement and would be determined based on the use of appraisals and input from market participants. Debt — The table below presents the estimated fair value of certain financial instruments not recorded at fair value on a recurring basis. The carrying amounts of the term loan approximates fair value. The term loan is classified as a Level 2 measurement according to the fair value hierarchy. The fair values of the senior unsecured notes are obtained from broker prices and are classified as Level 1 measurements according to the fair value hierarchy. January 30, 2021 October 31, 2020 Principal Amount Outstanding Fair Value Principal Amount Outstanding Fair Value 3-Year term loan, due March 2022 $ 925,000 $ 925,000 $ 925,000 $ 925,000 2.50% Senior unsecured notes, due December 2021 400,000 406,774 400,000 $ 408,565 2.875% Senior unsecured notes, due June 2023 500,000 526,131 500,000 $ 526,855 3.125% Senior unsecured notes, due December 2023 550,000 590,115 550,000 $ 590,177 2.95% Senior unsecured notes, due April 2025 400,000 434,027 400,000 $ 434,919 3.90% Senior unsecured notes, due December 2025 850,000 966,168 850,000 $ 969,033 3.50% Senior unsecured notes, due December 2026 900,000 1,015,998 900,000 $ 1,017,505 4.50% Senior unsecured notes, due December 2036 250,000 321,995 250,000 $ 298,153 5.30% Senior unsecured notes, due December 2045 400,000 558,870 400,000 $ 538,788 Total debt $ 5,175,000 $ 5,745,078 $ 5,175,000 $ 5,708,995 As of January 30, 2021, the Company believed that none of its unrealized losses on its available-for-sale investments were attributable to credit losses and therefore were not impaired. The investments with unrealized losses consisted primarily of corporate debt securities. In making the determination that the decline in fair value of these securities did not indicate impairment, the Company considered various factors, including, but not limited to: the extent to which fair value was less than cost; the financial condition and near-term prospects of the issuers; and the Company’s intent not to sell these securities and the assessment that it is more likely than not that the Company would not be required to sell these securities before the recovery of their amortized cost basis. Unrealized gains and losses, net of taxes, are reported as a component of AOCI in the Company’s Condensed Consolidated Statements of Stockholders’ Equity. No material amounts were reclassified out of AOCI during the three months ended January 30, 2021 and February 1, 2020 for realized gains or losses on available-for-sale investments.

Derivatives

Derivatives	3 Months Ended
	Jan. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	Derivatives Foreign Exchange Exposure Management — The Company enters into forward foreign currency exchange contracts to offset certain operational and balance sheet exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company’s operations, assets and liabilities that are denominated in currencies other than the U.S. dollar, primarily the Euro; other significant exposures include the British Pound, Philippine Peso and the Japanese Yen. Derivative instruments are employed to eliminate or minimize certain foreign currency exposures that can be confidently identified and quantified. These foreign currency exchange contracts are entered into to support transactions made in the normal course of business, and accordingly, are not speculative in nature. The contracts are for periods consistent with the terms of the underlying transactions, generally one year or less. Hedges related to anticipated transactions are matched with the underlying exposures at inception and designated and documented as cash flow hedges. They are qualitatively evaluated for effectiveness on a quarterly basis. The gain or loss on the derivative is recorded as a component of AOCI in shareholders’ equity and is reclassified into earnings in the same line item on the Consolidated Statements of Income as the impact of the hedged transaction in the same period during which the hedged transaction affects earnings. The total notional amounts of forward foreign currency derivative instruments designated as hedging instruments of cash flow hedges denominated in Euros, British Pounds, Philippine Pesos and Japanese Yen as of January 30, 2021 and October 31, 2020 were $217.0 million and $202.7 million, respectively. The fair values of forward foreign currency derivative instruments designated as hedging instruments in the Company’s Condensed Consolidated Balance Sheets as of January 30, 2021 and October 31, 2020 were as follows: Fair Value At Balance Sheet Location January 30, 2021 October 31, 2020 Forward foreign currency exchange contracts Prepaid expenses and other current assets $ 7,490 $ 5,550 As of January 30, 2021 and October 31, 2020, the total notional amounts of undesignated hedges related to forward foreign currency exchange contracts were $87.5 million and $62.7 million, respectively. The fair values of these hedging instruments in the Company’s Condensed Consolidated Balance Sheets were immaterial as of January 30, 2021 and October 31, 2020. The Company estimates that $5.1 million, net of tax, of settlements of forward foreign currency derivative instruments included in AOCI will be reclassified into earnings within the next 12 months. All the Company’s derivative financial instruments are eligible for netting arrangements that allow the Company and its counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled under these arrangements have been presented in the Company's Condensed Consolidated Balance Sheets on a net basis. As of January 30, 2021 and October 31, 2020, none of the netting arrangements involved collateral. The following table presents the gross amounts of the Company's forward foreign currency exchange contract derivative assets and liabilities and the net amounts recorded in the Company's Condensed Consolidated Balance Sheets: January 30, 2021 October 31, 2020 Gross amount of recognized assets $ 7,737 $ 6,114 Gross amounts of recognized liabilities offset in the Condensed Consolidated Balance Sheets (351) (687) Net assets presented in the Condensed Consolidated Balance Sheets $ 7,386 $ 5,427 As of January 30, 2021 and October 31, 2020, the fair value of the interest rate swap agreement designated as a cash flow hedge was $185.3 million and $214.6 million, respectively, and is included within Accrued liabilities in the Company's Condensed Consolidated Balance Sheets. The market risk associated with the Company’s derivative instruments results from currency exchange rate or interest rate movements that are expected to offset the market risk of the underlying transactions, assets and liabilities being hedged. The counterparties to the agreements relating to the Company’s derivative instruments consist of a number of major international financial institutions with high credit ratings. Based on the credit ratings of the Company’s counterparties as of January 30, 2021 and October 31, 2020, nonperformance is not perceived to be a material risk. Furthermore, none of the Company’s derivatives are subject to collateral or other security arrangements and none contain provisions that are dependent on the Company’s credit ratings from any credit rating agency. While the contract or notional amounts of derivative financial instruments provide one measure of the volume of these transactions, they do not represent the amount of the Company’s exposure to credit risk. The amounts potentially subject to credit risk (arising from the possible inability of counterparties to meet the terms of their contracts) are generally limited to the amounts, if any, by which the counterparties’ obligations under the contracts exceed the obligations of the Company to the counterparties. As a result of the above considerations, the Company does not consider the risk of counterparty default to be significant. For information on the unrealized holding gains (losses) on derivatives included in and reclassified out of AOCI into the Condensed Consolidated Statements of Income related to forward foreign currency exchange contracts, see Note 3, Accumulated Other Comprehensive (Loss) Income, in these Notes to Condensed Consolidated Financial Statements for further information.

Inventories

Inventories	3 Months Ended
	Jan. 30, 2021
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories at January 30, 2021 and October 31, 2020 were as follows: January 30, 2021 October 31, 2020 Raw materials $ 35,618 $ 33,806 Work in process 444,083 443,690 Finished goods 138,939 130,764 Total inventories $ 618,640 $ 608,260

Income Taxes

Income Taxes	3 Months Ended
	Jan. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company’s effective tax rates for the three-month periods ended January 30, 2021 and February 1, 2020 were below the U.S. statutory tax rate of 21.0%, due to lower statutory tax rates applicable to the Company's operations in the foreign jurisdictions in which it earns income. The Company has numerous audits ongoing throughout the world including: an IRS income tax audit for the fiscal years ended November 3, 2018 (fiscal 2018) and November 2, 2019 (fiscal 2019); various U.S. state and local tax audits; and international audits, including the transfer pricing audit in Ireland discussed below. The Company's U.S. federal tax returns prior to the fiscal year ended October 28, 2017 (fiscal 2017) are no longer subject to examination.

New Accounting Pronouncements

New Accounting Pronouncements	3 Months Ended
	Jan. 30, 2021
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Pronouncements	New Accounting Pronouncements Standards Implemented Financial Instruments In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments (ASU 2016-13). ASU 2016-13 requires a financial asset (or group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. In 2019, the FASB issued ASU 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief (ASU 2019-05) and ASU 2019-11, Codification Improvements to Topic 326 (ASU 2019-11). ASU 2019-05 allows an entity to irrevocably elect the fair value option for certain financial instruments. Once elected, an entity would recognize the difference between the carrying amount and the fair value of the financial instrument as part of the cumulative effect adjustments associated with the adoption of ASU 2016-13. ASU 2019-11 allows entities to exclude the accrued interest component of amortized cost from various disclosures required by ASC 326. The Company is exposed to credit losses through sales of its products and certain financial instruments. The Company determines if there is an expected loss on its accounts receivables using historical collection experience, current and future economic and market conditions and a review of the current status of customers' trade accounts receivables. The Company adopted these standards effective November 1, 2020 using the modified retrospective approach, which did not have a material impact on the Company's financial position and results of operations. See Note 8, Fair Value, in these Notes to Condensed Consolidated Financial Statements for more information related to how the Company assesses credit losses on its available-for-sale debt securities. Income taxes In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes . ASU 2019-12 eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. The Company adopted ASU 2019-12 in the first quarter of fiscal 2021. Upon adoption, ASU 2019-12 did not have a material impact on the Company's financial position and results of operations. Retirement Benefits In August 2018, the FASB issued ASU 2018-14, Compensation-Retirement Benefits-Defined Benefit Plans-General (Topic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans (ASU 2018-14), which modifies the disclosure requirements for defined benefit pension plans and other post-retirement plans. ASU 2018-14 is effective for fiscal years ending after December 15, 2020, with early adoption permitted. The Company adopted ASU 2018-14 in the first quarter of fiscal 2021. Upon adoption, ASU 2018-14 did not have a material impact on the Company's financial position and results of operations. Standards to Be Implemented Reference Rate Reform In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides optional guidance for accounting for contracts, hedging relationships, and other transactions affected by reference rate reform, if certain criteria are met. The provisions of this standard are available for election through December 31, 2022. The Company is currently evaluating the impact of the reference rate reform on its contracts and the resulting impact of adopting this standard on our financial statements.

Acquisitions

Acquisitions	3 Months Ended
	Jan. 30, 2021
Business Combinations [Abstract]
Acquisitions	Acquisitions Proposed acquisition of Maxim Integrated Products, Inc. On July 12, 2020, the Company entered into the Merger Agreement to acquire Maxim, an independent manufacturer of innovative analog and mixed-signal products and technologies. Under the terms of the Merger Agreement, Maxim stockholders will receive, for each outstanding share of Maxim common stock, 0.630 of a share of the Company’s common stock at the closing. The estimated merger consideration is approximately $27.0 billion based on the closing price of the Company's common stock on February 12, 2021. The value of the merger consideration will fluctuate based upon changes in the price of the Company's common stock and the number of shares of Maxim common stock, restricted stock awards and restricted stock unit awards outstanding on the closing date. The transaction is subject to customary closing conditions, including receipt of certain non-U.S. regulatory approvals. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, has expired. The Merger Agreement includes termination rights for both the Company and Maxim. The Company may be required to pay Maxim a regulatory termination fee of $830.0 million in cash if the Merger Agreement is terminated in certain circumstances involving the failure to obtain required regulatory approvals. On October 8, 2020, the required shareholder approvals relating to the Merger Agreement were obtained from both the Company's shareholders and Maxim's shareholders. In the first three months of fiscal 2021, the Company incurred $15.2 million of transaction-related costs recorded within Selling, marketing, general and administrative expenses in the Company's Condensed Consolidated Statement of Income. Maxim Merger Litigation

Subsequent Events

Subsequent Events	3 Months Ended
	Jan. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsOn February 16, 2021, the Board of Directors of the Company declared a cash dividend of $0.69 per outstanding share of common stock. The dividend will be paid on March 9, 2021 to all shareholders of record at the close of business on February 26, 2021 and is expected to total approximately $254.5 million.

Basis of Presentation (Policies

Basis of Presentation (Policies)	3 Months Ended
	Jan. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Fiscal Period	The Company has a 52-53 week fiscal year that ends on the Saturday closest to the last day in October. Certain amounts reported in previous periods have been reclassified to conform to the fiscal 2021 presentation.
Fair Value	The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments: Cash equivalents — These investments are adjusted to fair value based on quoted market prices or are determined using a yield curve model based on current market rates. Deferred compensation plan investments — The fair value of these mutual fund, money market fund and equity investments are based on quoted market prices. Interest rate derivatives — The fair value of the interest rate derivatives is estimated using a discounted cash flow analysis based on the contractual terms of the derivative. Forward foreign currency exchange contracts — The estimated fair value of forward foreign currency exchange contracts, which includes derivatives that are accounted for as cash flow hedges and those that are not designated as cash flow hedges, is based on the estimated amount the Company would receive if it sold these agreements at the reporting date taking into consideration current interest rates as well as the creditworthiness of the counterparty for assets and the Company’s creditworthiness for liabilities. The fair value of these instruments is based upon valuation models using current market information such as strike price, spot rate, maturity date and volatility.
Derivatives	Foreign Exchange Exposure Management — The Company enters into forward foreign currency exchange contracts to offset certain operational and balance sheet exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company’s operations, assets and liabilities that are denominated in currencies other than the U.S. dollar, primarily the Euro; other significant exposures include the British Pound, Philippine Peso and the Japanese Yen. Derivative instruments are employed to eliminate or minimize certain foreign currency exposures that can be confidently identified and quantified. These foreign currency exchange contracts are entered into to support transactions made in the normal course of business, and accordingly, are not speculative in nature. The contracts are for periods consistent with the terms of the underlying transactions, generally one year or less. Hedges related to anticipated transactions are matched with the underlying exposures at inception and designated and documented as cash flow hedges. They are qualitatively evaluated for effectiveness on a quarterly basis. The gain or loss on the derivative is recorded as a component of AOCI in shareholders’ equity and is reclassified into earnings in the same line item on the Consolidated Statements of Income as the impact of the hedged transaction in the same period during which the hedged transaction affects earnings.
Standards Implemented	Standards Implemented Financial Instruments In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments (ASU 2016-13). ASU 2016-13 requires a financial asset (or group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. In 2019, the FASB issued ASU 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief (ASU 2019-05) and ASU 2019-11, Codification Improvements to Topic 326 (ASU 2019-11). ASU 2019-05 allows an entity to irrevocably elect the fair value option for certain financial instruments. Once elected, an entity would recognize the difference between the carrying amount and the fair value of the financial instrument as part of the cumulative effect adjustments associated with the adoption of ASU 2016-13. ASU 2019-11 allows entities to exclude the accrued interest component of amortized cost from various disclosures required by ASC 326. The Company is exposed to credit losses through sales of its products and certain financial instruments. The Company determines if there is an expected loss on its accounts receivables using historical collection experience, current and future economic and market conditions and a review of the current status of customers' trade accounts receivables. The Company adopted these standards effective November 1, 2020 using the modified retrospective approach, which did not have a material impact on the Company's financial position and results of operations. See Note 8, Fair Value, in these Notes to Condensed Consolidated Financial Statements for more information related to how the Company assesses credit losses on its available-for-sale debt securities. Income taxes In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes . ASU 2019-12 eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. The Company adopted ASU 2019-12 in the first quarter of fiscal 2021. Upon adoption, ASU 2019-12 did not have a material impact on the Company's financial position and results of operations. Retirement Benefits In August 2018, the FASB issued ASU 2018-14, Compensation-Retirement Benefits-Defined Benefit Plans-General (Topic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans (ASU 2018-14), which modifies the disclosure requirements for defined benefit pension plans and other post-retirement plans. ASU 2018-14 is effective for fiscal years ending after December 15, 2020, with early adoption permitted. The Company adopted ASU 2018-14 in the first quarter of fiscal 2021. Upon adoption, ASU 2018-14 did not have a material impact on the Company's financial position and results of operations. Standards to Be Implemented Reference Rate Reform In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides optional guidance for accounting for contracts, hedging relationships, and other transactions affected by reference rate reform, if certain criteria are met. The provisions of this standard are available for election through December 31, 2022. The Company is currently evaluating the impact of the reference rate reform on its contracts and the resulting impact of adopting this standard on our financial statements.

Stock-Based Compensation and _2

Stock-Based Compensation and Shareholders' Equity (Tables)	3 Months Ended
	Jan. 30, 2021
Share-based Payment Arrangement [Abstract]
Summary of the activity under the company's stock option plans	A summary of the Company’s stock option activity as of January 30, 2021 and changes during the three-month period then ended is presented below: Options Outstanding (in thousands) Weighted- Average Exercise Price Per Share Weighted- Average Remaining Contractual Term in Years Aggregate Intrinsic Value Options outstanding at October 31, 2020 4,192 $70.73 Options granted 460 $144.06 Options exercised (349) $56.94 Options forfeited (21) $85.53 Options expired (5) $37.52 Options outstanding at January 30, 2021 4,277 $79.71 5.9 $289,219 Options exercisable at January 30, 2021 2,332 $61.96 4.4 $199,072 Options vested or expected to vest at January 30, 2021 (1) 4,158 $78.63 5.9 $285,622 (1) In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. The number of options expected to vest is calculated by applying an estimated forfeiture rate to the unvested options.
Schedule of share-based compensation, restricted stock units award activity	A summary of the Company’s restricted stock unit/award activity as of January 30, 2021 and changes during the three-month period then ended is presented below: Restricted Stock Units/Awards Outstanding (in thousands) Weighted- Average Grant- Date Fair Value Per Share Restricted stock units/awards outstanding at October 31, 2020 3,637 $91.54 Units/Awards granted 196 $138.21 Restrictions lapsed (135) $86.08 Forfeited (59) $99.73 Restricted stock units/awards outstanding at January 30, 2021 3,639 $92.02
Schedule of stock-based compensation expense	Total stock-based compensation expense recognized was as follows: Three Months Ended January 30, 2021 February 1, 2020 Cost of sales $ 4,354 $ 4,564 Research and development 18,321 17,605 Selling, marketing, general and administrative 13,963 15,332 Total stock-based compensation expense $ 36,638 $ 37,501

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive (Loss) Income (Tables)	3 Months Ended
	Jan. 30, 2021
Equity [Abstract]
Components of accumulated other comprehensive loss, net of tax	The following table provides the changes in accumulated other comprehensive (loss) income (AOCI) by component and the related tax effects during the first three months of fiscal 2021. Foreign currency translation adjustment Unrealized holding gains (losses) on derivatives Pension plans Total October 31, 2020 $ (26,852) $ (172,670) $ (49,939) $ (249,461) Other comprehensive income (loss) before reclassifications 8,279 34,930 (2,446) 40,763 Amounts reclassified out of other comprehensive income (loss) — (3,804) 748 (3,056) Tax effects — (6,661) (86) (6,747) Other comprehensive income (loss) 8,279 24,465 (1,784) 30,960 January 30, 2021 $ (18,573) $ (148,205) $ (51,723) $ (218,501)
Schedule of reclassification out of accumulated other comprehensive income	The amounts reclassified out of AOCI into the Condensed Consolidated Statements of Income and the Condensed Consolidated Statements of Shareholders' Equity with presentation location during each period were as follows: Three Months Ended Comprehensive Income Component January 30, 2021 February 1, 2020 Location Unrealized holding losses (gains) on derivatives Currency forwards $ (1,986) $ (80) Cost of sales (1,064) 378 Research and development (1,218) 532 Selling, marketing, general and administrative Interest rate derivatives 464 464 Interest expense (3,804) 1,294 Total before tax 204 (370) Tax Effect of Accounting Standards Update 2018-02 — (2,379) Retained earnings $ (3,600) $ (1,455) Net of tax Amortization of pension components included in the computation of net periodic pension cost Actuarial losses 748 648 (86) (160) Tax $ 662 $ 488 Net of tax Total amounts reclassified out of AOCI, net of tax $ (2,938) $ (967)

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Jan. 30, 2021
Earnings Per Share [Abstract]
Computation of basic and diluted earnings per share	The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended January 30, 2021 February 1, 2020 Net Income $ 388,519 $ 203,874 Basic shares: Weighted-average shares outstanding 369,203 368,241 Earnings per common share basic: $ 1.05 $ 0.55 Diluted shares: Weighted-average shares outstanding 369,203 368,241 Assumed exercise of common stock equivalents 3,903 4,023 Weighted-average common and common equivalent shares 373,106 372,264 Earnings per common share diluted: $ 1.04 $ 0.55 Anti-dilutive shares related to: Outstanding stock-based awards 239 397

Special Charges (Tables)

Special Charges (Tables)	3 Months Ended
	Jan. 30, 2021
Restructuring and Related Activities [Abstract]
Schedule of accrued restructuring	The following table is a quarterly roll-forward from October 31, 2020 to January 30, 2021 of the employee separation and exit cost accruals established related to existing restructuring actions: Accrued Restructuring Closure of Manufacturing Facilities Repositioning Action Other Actions Balance at October 31, 2020 $ 45,176 $ 20,774 $ 3,489 First quarter fiscal 2021 special charges 438 — — Severance and other payments (1,950) (8,128) (333) Effect of foreign currency on accrual — 248 — Balance at January 30, 2021 $ 43,664 $ 12,894 $ 3,156 Current - accrued liabilities $ 33,433 $ 12,894 $ 3,156 Other non-current liabilities $ 10,231 $ — $ —

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	3 Months Ended
	Jan. 30, 2021
Property, Plant and Equipment [Abstract]
Schedule of long lived assets held-for-sale	As shown below, this carrying value was reclassified from various line items within Property, plant and equipment to Prepaid expenses and other current assets upon designation and remains in Prepaid expenses and other current assets as of January 30, 2021. Land and buildings $ 36,451 Machinery and equipment 1,468 Office equipment 197 Leasehold improvements 5,744 43,860 Less accumulated depreciation and amortization (21,706) Net property, plant and equipment reclassified to Prepaid expenses and other current assets $ 22,154

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
	Jan. 30, 2021
Segment Reporting [Abstract]
Disaggregation of revenue	The following table summarizes revenue by end market. The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the “sold to” customer information, the “ship to” customer information and the end customer product or application into which the Company’s product will be incorporated. As data systems for capturing and tracking this data and the Company's methodology evolves and improves, the categorization of products by end market can vary over time. When this occurs, the Company reclassifies revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of results within, each end market. Three Months Ended January 30, 2021 February 1, 2020 Revenue % of Revenue* Y/Y% Revenue % of Revenue* Industrial $ 855,454 55 % 24 % $ 687,685 53 % Communications 281,049 18 % 16 % 241,804 19 % Automotive 245,250 16 % 19 % 205,712 16 % Consumer 176,705 11 % 5 % 168,364 13 % Total revenue $ 1,558,458 100 % 20 % $ 1,303,565 100 % * The sum of the individual percentages may not equal the total due to rounding. Three Months Ended January 30, 2021 February 1, 2020 Channel Revenue % of Revenue* Revenue % of Revenue* Distributors $ 946,386 61 % $ 747,561 57 % Direct customers 589,456 38 % 529,731 41 % Other 22,616 1 % 26,273 2 % Total revenue $ 1,558,458 100 % $ 1,303,565 100 % * The sum of the individual percentages may not equal the total due to rounding.

Fair Value (Tables)

Fair Value (Tables)	3 Months Ended
	Jan. 30, 2021
Fair Value Disclosures [Abstract]
Schedule of fair value of financial assets and liabilities	The tables below, set forth by level, presents the Company’s financial assets and liabilities, excluding accrued interest components that were accounted for at fair value on a recurring basis as of January 30, 2021 and October 31, 2020. The tables exclude cash on hand and assets and liabilities that are measured at historical cost or any basis other than fair value. As of January 30, 2021 and October 31, 2020, the Company held $205.7 million and $239.6 million, respectively, of cash and held-to-maturity investments that were excluded from the tables below. January 30, 2021 Fair Value measurement at Reporting Date using: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Total Assets Cash equivalents: Available-for-sale: Government and institutional money market funds $ 822,348 $ — $ 822,348 Corporate obligations (1) — 19,998 19,998 Other assets: Deferred compensation investments 59,490 — 59,490 Forward foreign currency exchange contracts (2) — 7,386 7,386 Total assets measured at fair value $ 881,838 $ 27,384 $ 909,222 Liabilities Interest rate derivatives $ — $ 185,349 $ 185,349 Total liabilities measured at fair value $ — $ 185,349 $ 185,349 (1) The amortized cost of the Company’s investments classified as available-for-sale as of January 30, 2021 was $20.0 million. (2) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 9, Derivatives, in these Notes to Condensed Consolidated Financial Statements for more information related to the Company's master netting arrangements. October 31, 2020 Fair Value measurement at Reporting Date using: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Total Assets Cash equivalents: Available-for-sale: Government and institutional money market funds $ 816,253 $ — $ 816,253 Other assets: Forward foreign currency exchange contracts (1) — 5,427 5,427 Deferred compensation investments 52,956 — 52,956 Total assets measured at fair value $ 869,209 $ 5,427 $ 874,636 Liabilities Interest rate derivatives $ — $ 214,586 $ 214,586 Total liabilities measured at fair value $ — $ 214,586 $ 214,586 (1) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 9, Derivatives, in these Notes to Condensed Consolidated Financial Statements for more information related to the Company's master netting arrangements.
Schedule of debt	The table below presents the estimated fair value of certain financial instruments not recorded at fair value on a recurring basis. The carrying amounts of the term loan approximates fair value. The term loan is classified as a Level 2 measurement according to the fair value hierarchy. The fair values of the senior unsecured notes are obtained from broker prices and are classified as Level 1 measurements according to the fair value hierarchy. January 30, 2021 October 31, 2020 Principal Amount Outstanding Fair Value Principal Amount Outstanding Fair Value 3-Year term loan, due March 2022 $ 925,000 $ 925,000 $ 925,000 $ 925,000 2.50% Senior unsecured notes, due December 2021 400,000 406,774 400,000 $ 408,565 2.875% Senior unsecured notes, due June 2023 500,000 526,131 500,000 $ 526,855 3.125% Senior unsecured notes, due December 2023 550,000 590,115 550,000 $ 590,177 2.95% Senior unsecured notes, due April 2025 400,000 434,027 400,000 $ 434,919 3.90% Senior unsecured notes, due December 2025 850,000 966,168 850,000 $ 969,033 3.50% Senior unsecured notes, due December 2026 900,000 1,015,998 900,000 $ 1,017,505 4.50% Senior unsecured notes, due December 2036 250,000 321,995 250,000 $ 298,153 5.30% Senior unsecured notes, due December 2045 400,000 558,870 400,000 $ 538,788 Total debt $ 5,175,000 $ 5,745,078 $ 5,175,000 $ 5,708,995

Derivatives (Tables)

Derivatives (Tables)	3 Months Ended
	Jan. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of fair value of hedging instruments	The fair values of forward foreign currency derivative instruments designated as hedging instruments in the Company’s Condensed Consolidated Balance Sheets as of January 30, 2021 and October 31, 2020 were as follows: Fair Value At Balance Sheet Location January 30, 2021 October 31, 2020 Forward foreign currency exchange contracts Prepaid expenses and other current assets $ 7,490 $ 5,550
Schedule of net amount of derivative assets and liabilities	The following table presents the gross amounts of the Company's forward foreign currency exchange contract derivative assets and liabilities and the net amounts recorded in the Company's Condensed Consolidated Balance Sheets: January 30, 2021 October 31, 2020 Gross amount of recognized assets $ 7,737 $ 6,114 Gross amounts of recognized liabilities offset in the Condensed Consolidated Balance Sheets (351) (687) Net assets presented in the Condensed Consolidated Balance Sheets $ 7,386 $ 5,427

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Jan. 30, 2021
Inventory Disclosure [Abstract]
Schedule of inventories	Inventories at January 30, 2021 and October 31, 2020 were as follows: January 30, 2021 October 31, 2020 Raw materials $ 35,618 $ 33,806 Work in process 444,083 443,690 Finished goods 138,939 130,764 Total inventories $ 618,640 $ 608,260

Stock-Based Compensation and _3

Stock-Based Compensation and Shareholders' Equity - Outstanding Compensation (Details) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Jan. 30, 2021USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Options outstanding, weighted-average remaining contractual term in years	5 years 10 months 24 days
Options exercisable, weighted-average remaining contractual term in years	4 years 4 months 24 days
Options vested or expected to vest, weighted-average remaining contractual term in years	5 years 10 months 24 days
Options outstanding, aggregate intrinsic value | $	$ 289,219
Options exercisable, aggregate intrinsic value | $	199,072
Options vested or expected to vest, aggregate intrinsic value | $	$ 285,622
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options outstanding, at beginning of period (in shares) | shares	4,192
Options granted (in shares) | shares	460
Options exercised (in shares) | shares	(349)
Options forfeited (in shares) | shares	(21)
Options expired (in shares) | shares	(5)
Options outstanding, at end of period (in shares) | shares	4,277
Options exercisable (in shares) | shares	2,332
Options vested or expected to vest (in shares) | shares	4,158
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Options outstanding, weighted-average exercise price per share, at beginning of period (in dollars per share) | $ / shares	$ 70.73
Options granted, weighted-average exercise price per share (in dollars per share) | $ / shares	144.06
Options exercised, weighted-average exercise price per share (in dollars per share) | $ / shares	56.94
Options forfeited, weighted-average exercise price per share (in dollars per share) | $ / shares	85.53
Options expired, weighted-average exercise price per share (in dollars per share) | $ / shares	37.52
Options outstanding, weighted-average exercise price per share, at end of period (in dollars per share) | $ / shares	79.71
Options exercisable, weighted-average exercise price per share (in dollars per share) | $ / shares	61.96
Options vested or expected to vest, weighted-average exercise price per share (in dollars per share) | $ / shares	$ 78.63
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Restricted stock units/awards outstanding, at beginning of period (in shares) | shares	3,637
Units/Awards granted (in shares) | shares	196
Restrictions lapsed (in shares) | shares	(135)
Forfeited (in shares) | shares	(59)
Restricted stock units/awards outstanding, at end of period (in shares) | shares	3,639
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Restricted stock units/awards outstanding, at beginning of period (in dollar per shares) | $ / shares	$ 91.54
Units/Awards granted (in dollar per shares) | $ / shares	138.21
Restrictions lapsed (in dollar per shares) | $ / shares	86.08
Forfeited (in dollar per shares) | $ / shares	99.73
Restricted stock units/awards outstanding, at end of period (in dollar per shares) | $ / shares	$ 92.02

Stock-Based Compensation and _4

Stock-Based Compensation and Shareholders' Equity - Textual (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Jan. 30, 2021	Feb. 01, 2020	Oct. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total intrinsic value of options exercised	$ 30.4	$ 20.3
Total unrecognized compensation cost related to unvested share-based awards, before tax consideration	$ 267.1
Weighted-average period to recognize compensation cost	1 year 3 months 18 days
Total grant-date fair value of vested stock options	$ 15.6	$ 14.8
Stock-based compensation	$ 5.7		$ 5.8
Number of shares authorized to be repurchased (shares)	157,100
Stock repurchase program, authorized amount	$ 1,700
Performance Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized (in shares)	460
Exercise price per share (in dollars per share)	$ 144.06
Award vesting period	5 years
Average closing price period	70 days
Maxim | Performance-based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	2 years
Units granted (in shares)	110
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase program, authorized amount	$ 6,400
Maximum | Performance Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage	100.00%
Maximum | Maxim | Performance-based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage	200.00%
Minimum | Performance Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage	0.00%
Minimum | Maxim | Performance-based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage	0.00%

Stock-Based Compensation and _5

Stock-Based Compensation and Shareholders' Equity - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 30, 2021	Feb. 01, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 36,638	$ 37,501
Cost of sales
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	4,354	4,564
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	18,321	17,605
Selling, marketing, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 13,963	$ 15,332

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive (Loss) Income - Changes By Component and Tax Effect (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 30, 2021	Feb. 01, 2020
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 11,997,945
Other comprehensive income (loss) before reclassifications	40,763
Amounts reclassified out of other comprehensive income (loss)	(3,056)
Tax effects	(6,747)
Other comprehensive income (loss)	30,960	$ (11,969)
Ending balance	12,087,746
AOCI
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(249,461)	(187,799)
Other comprehensive income (loss)	30,960	(11,969)
Ending balance	(218,501)	$ (202,147)
Foreign currency translation adjustment
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(26,852)
Other comprehensive income (loss) before reclassifications	8,279
Amounts reclassified out of other comprehensive income (loss)	0
Tax effects	0
Other comprehensive income (loss)	8,279
Ending balance	(18,573)
Unrealized holding gains (losses) on derivatives
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(172,670)
Other comprehensive income (loss) before reclassifications	34,930
Amounts reclassified out of other comprehensive income (loss)	(3,804)
Tax effects	(6,661)
Other comprehensive income (loss)	24,465
Ending balance	(148,205)
Pension plans
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(49,939)
Other comprehensive income (loss) before reclassifications	(2,446)
Amounts reclassified out of other comprehensive income (loss)	748
Tax effects	(86)
Other comprehensive income (loss)	(1,784)
Ending balance	$ (51,723)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive (Loss) Income - Amounts Reclassified Out of Accumulated Other Comprehensive (Loss) Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 30, 2021	Feb. 01, 2020	Oct. 31, 2020	Nov. 02, 2019
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	$ 513,087	$ 455,423
Research and development	288,150	257,073
Selling, marketing, general and administrative	185,275	199,280
Interest expense	42,479	48,813
Total before tax	436,618	226,217
Tax	$ (48,099)	$ (22,343)
Accounting standards update [extensible list]	us-gaap:AccountingStandardsUpdate201802Member	us-gaap:AccountingStandardsUpdate201802Member
Effect of Accounting Standards Update	$ (12,087,746)		$ (11,997,945)
Total before tax	(3,056)
Net of tax	(2,938)	$ (967)
Unrealized holding gains (losses) on derivatives
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Effect of Accounting Standards Update	148,205		172,670
Total before tax	(3,804)
Pension plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Effect of Accounting Standards Update	51,723		49,939
Total before tax	748
Retained earnings
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Effect of Accounting Standards Update	(7,395,578)	(6,906,346)	$ (7,236,238)	$ (6,899,253)
Retained earnings | Cumulative effect, period of adoption, adjustment
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Effect of Accounting Standards Update				$ (2,379)
Reclassification out of Accumulated Other Comprehensive Income | Unrealized holding gains (losses) on derivatives
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net of tax	(3,600)	(1,455)
Reclassification out of Accumulated Other Comprehensive Income | Pension plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Tax	(86)	(160)
Net of tax	662	488
Reclassification out of Accumulated Other Comprehensive Income | Actuarial losses
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total before tax	748	648
Reclassification out of Accumulated Other Comprehensive Income | Retained earnings | Cumulative effect, period of adoption, adjustment
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Effect of Accounting Standards Update	0	(2,379)
Reclassification out of Accumulated Other Comprehensive Income | Currency forwards | Unrealized holding gains (losses) on derivatives
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	(1,986)	(80)
Research and development	(1,064)	378
Selling, marketing, general and administrative	(1,218)	532
Reclassification out of Accumulated Other Comprehensive Income | Interest rate derivatives | Unrealized holding gains (losses) on derivatives
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest expense	464	464
Total before tax	(3,804)	1,294
Tax	$ 204	$ (370)

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Jan. 30, 2021	Feb. 01, 2020
Earnings per share
Net Income	$ 388,519	$ 203,874
Basic shares:
Weighted-average shares outstanding (in shares)	369,203	368,241
Earnings per common share, basic (in dollars per share)	$ 1.05	$ 0.55
Diluted shares:
Weighted-average shares outstanding (in shares)	369,203	368,241
Assumed exercise of common stock equivalents (in shares)	3,903	4,023
Weighted-average common and common equivalent shares (in shares)	373,106	372,264
Earnings per common share, diluted (in dollars per share)	$ 1.04	$ 0.55
Anti-dilutive shares related to:
Outstanding share-based awards (in shares)	239	397

Special Charges - Restructuring

Special Charges - Restructuring (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 30, 2021	Feb. 01, 2020
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Special charges	$ 438	$ 11,136
Closure of Manufacturing Facilities
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Accrued restructuring, beginning balance	45,176
Special charges	438
Severance and other payments	(1,950)
Effect of foreign currency on accrual	0
Accrued restructuring, ending balance	43,664
Closure of Manufacturing Facilities | Accrued liabilities
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Accrued restructuring, ending balance	33,433
Closure of Manufacturing Facilities | Other non-current liabilities
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Accrued restructuring, ending balance	10,231
Repositioning Action
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Accrued restructuring, beginning balance	20,774
Special charges	0
Severance and other payments	(8,128)
Effect of foreign currency on accrual	248
Accrued restructuring, ending balance	12,894
Repositioning Action | Accrued liabilities
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Accrued restructuring, ending balance	12,894
Repositioning Action | Other non-current liabilities
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Accrued restructuring, ending balance	0
Other Actions
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Accrued restructuring, beginning balance	3,489
Special charges	0
Severance and other payments	(333)
Effect of foreign currency on accrual	0
Accrued restructuring, ending balance	3,156
Other Actions | Accrued liabilities
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Accrued restructuring, ending balance	3,156
Other Actions | Other non-current liabilities
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Accrued restructuring, ending balance	$ 0

Special Charges - Textual (Deta

Special Charges - Textual (Details) - USD ($) $ in Millions	12 Months Ended
	Nov. 02, 2019	Jan. 30, 2021
Repositioning Action
Restructuring Cost and Reserve [Line Items]
Special charges, cumulative		$ 137.5
Repositioning Action | Intellectual Property
Restructuring Cost and Reserve [Line Items]
Impairment of intangible assets, finite-lived	$ 14.2
Severance and Fringe Benefits
Restructuring Cost and Reserve [Line Items]
Special charges, cumulative		123.3
Workforce Reduction Plan | Closure of Manufacturing Facilities
Restructuring Cost and Reserve [Line Items]
Special charges, cumulative		$ 55.4

Property, Plant and Equipment_2

Property, Plant and Equipment (Details) $ in Thousands	Jan. 30, 2021USD ($)
Long Lived Assets Held-for-sale [Line Items]
Property, plant and equipment, gross	$ 43,860
Less accumulated depreciation and amortization	(21,706)
Net property, plant and equipment reclassified to Prepaid expenses and other current assets	22,154
Land and buildings
Long Lived Assets Held-for-sale [Line Items]
Property, plant and equipment, gross	36,451
Machinery and equipment
Long Lived Assets Held-for-sale [Line Items]
Property, plant and equipment, gross	1,468
Office equipment
Long Lived Assets Held-for-sale [Line Items]
Property, plant and equipment, gross	197
Leasehold improvements
Long Lived Assets Held-for-sale [Line Items]
Property, plant and equipment, gross	$ 5,744

Segment Information - Textual (

Segment Information - Textual (Details)	3 Months Ended
	Jan. 30, 2021segment
Segment Reporting [Abstract]
Number of reportable segments	1
Number of operating segments	8

Segment Information - Revenue T

Segment Information - Revenue Trends by Segment (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 30, 2021	Feb. 01, 2020
Revenue Trends
Revenue	$ 1,558,458	$ 1,303,565
Percent of Revenue (as percent)	100.00%	100.00%
Year over Year Change (as percent)	20.00%
Operating Segments | Industrial
Revenue Trends
Revenue	$ 855,454	$ 687,685
Percent of Revenue (as percent)	55.00%	53.00%
Year over Year Change (as percent)	24.00%
Operating Segments | Communications
Revenue Trends
Revenue	$ 281,049	$ 241,804
Percent of Revenue (as percent)	18.00%	19.00%
Year over Year Change (as percent)	16.00%
Operating Segments | Automotive
Revenue Trends
Revenue	$ 245,250	$ 205,712
Percent of Revenue (as percent)	16.00%	16.00%
Year over Year Change (as percent)	19.00%
Operating Segments | Consumer
Revenue Trends
Revenue	$ 176,705	$ 168,364
Percent of Revenue (as percent)	11.00%	13.00%
Year over Year Change (as percent)	5.00%

Segment Information - Revenue b

Segment Information - Revenue by Sales Channel (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 30, 2021	Feb. 01, 2020
Segment Reporting Information [Line Items]
Revenue	$ 1,558,458	$ 1,303,565
Percent of Revenue (as percent)	100.00%	100.00%
Distributors
Segment Reporting Information [Line Items]
Revenue	$ 946,386	$ 747,561
Percent of Revenue (as percent)	61.00%	57.00%
Direct customers
Segment Reporting Information [Line Items]
Revenue	$ 589,456	$ 529,731
Percent of Revenue (as percent)	38.00%	41.00%
Other
Segment Reporting Information [Line Items]
Revenue	$ 22,616	$ 26,273
Percent of Revenue (as percent)	1.00%	2.00%

Fair Value - Textual (Details)

Fair Value - Textual (Details) - USD ($) $ in Millions	Jan. 30, 2021	Oct. 31, 2020
Fair Value Disclosures [Abstract]
Cash and held to maturity investments	$ 205.7	$ 239.6

Fair Value - Assets and Liabili

Fair Value - Assets and Liabilities (Details) - USD ($) $ in Thousands	Jan. 30, 2021	Oct. 31, 2020
Liabilities
Amortized cost	$ 20,000
Recurring
Other assets:
Deferred compensation investments	59,490	$ 52,956
Forward foreign currency exchange contracts	7,386	5,427
Total assets measured at fair value	909,222	874,636
Liabilities
Interest rate derivatives	185,349	214,586
Total liabilities measured at fair value	185,349	214,586
Recurring | Government and institutional money market funds
Available-for-sale:
Cash equivalents:	822,348	816,253
Recurring | Corporate obligations
Available-for-sale:
Cash equivalents:	19,998
Recurring | Level 1
Other assets:
Deferred compensation investments	59,490	52,956
Forward foreign currency exchange contracts	0	0
Total assets measured at fair value	881,838	869,209
Liabilities
Interest rate derivatives	0	0
Total liabilities measured at fair value	0	0
Recurring | Level 1 | Government and institutional money market funds
Available-for-sale:
Cash equivalents:	822,348	816,253
Recurring | Level 1 | Corporate obligations
Available-for-sale:
Cash equivalents:	0
Recurring | Level 2
Other assets:
Deferred compensation investments	0	0
Forward foreign currency exchange contracts	7,386	5,427
Total assets measured at fair value	27,384	5,427
Liabilities
Interest rate derivatives	185,349	214,586
Total liabilities measured at fair value	185,349	214,586
Recurring | Level 2 | Government and institutional money market funds
Available-for-sale:
Cash equivalents:	0	$ 0
Recurring | Level 2 | Corporate obligations
Available-for-sale:
Cash equivalents:	$ 19,998

Fair Value - Debt (Details)

Fair Value - Debt (Details) - Long-term Debt - USD ($)	3 Months Ended
	Jan. 30, 2021	Oct. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount Outstanding	$ 5,175,000,000	$ 5,175,000,000
Fair Value	$ 5,745,078,000	5,708,995,000
3-Year term loan, due March 2022 | Unsecured debt term
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt term	3 years
Principal Amount Outstanding	$ 925,000,000	925,000,000
Fair Value	$ 925,000,000	925,000,000
2.50% Senior unsecured notes, due December 2021 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	2.50%
Principal Amount Outstanding	$ 400,000,000	400,000,000
Fair Value	$ 406,774,000	408,565,000
2.875% Senior unsecured notes, due June 2023 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	2.875%
Principal Amount Outstanding	$ 500,000,000	500,000,000
Fair Value	$ 526,131,000	526,855,000
3.125% Senior unsecured notes, due December 2023 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	3.125%
Principal Amount Outstanding	$ 550,000,000	550,000,000
Fair Value	$ 590,115,000	590,177,000
2.95% Senior unsecured notes, due April 2025 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	2.95%
Principal Amount Outstanding	$ 400,000,000	400,000,000
Fair Value	$ 434,027,000	434,919,000
3.90% Senior unsecured notes, due December 2025 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	3.90%
Principal Amount Outstanding	$ 850,000,000	850,000,000
Fair Value	$ 966,168,000	969,033,000
3.50% Senior unsecured notes, due December 2026 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	3.50%
Principal Amount Outstanding	$ 900,000,000	900,000,000
Fair Value	$ 1,015,998,000	1,017,505,000
4.50% Senior unsecured notes, due December 2036 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	4.50%
Principal Amount Outstanding	$ 250,000,000	250,000,000
Fair Value	$ 321,995,000	298,153,000
5.30% Senior unsecured notes, due December 2045 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	5.30%
Principal Amount Outstanding	$ 400,000,000	400,000,000
Fair Value	$ 558,870,000	$ 538,788,000

Derivatives - Textual (Details)

Derivatives - Textual (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 30, 2021	Oct. 31, 2020
Derivative [Line Items]
Contracts period	1 year
Foreign currency cash flow hedge gain (loss) to be reclassified during next 12 months	$ 5,100
Derivative assets, fair value	7,737	$ 6,114
Forward Contracts
Derivative [Line Items]
Notional amount of cash flow hedges	217,000	202,700
Notional amount of derivative	87,500	62,700
Interest Rate Swap Agreements | Accrued liabilities | Designated as Hedging Instrument
Derivative [Line Items]
Derivative assets, fair value	$ 185,300	$ 214,600

Derivatives - Forward Foreign C

Derivatives - Forward Foreign Currency (Details) - USD ($) $ in Thousands	Jan. 30, 2021	Oct. 31, 2020
Forward foreign currency exchange contracts | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Foreign currency contracts, liability	$ 7,490	$ 5,550

Derivative - Net Amounts (Detai

Derivative - Net Amounts (Details) - USD ($) $ in Thousands	Jan. 30, 2021	Oct. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Gross amount of recognized assets	$ 7,737	$ 6,114
Gross amounts of recognized liabilities offset in the Condensed Consolidated Balance Sheets	(351)	(687)
Net assets presented in the Condensed Consolidated Balance Sheets	$ 7,386	$ 5,427

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Jan. 30, 2021	Oct. 31, 2020
Inventory Disclosure [Abstract]
Raw materials	$ 35,618	$ 33,806
Work in process	444,083	443,690
Finished goods	138,939	130,764
Total inventories	$ 618,640	$ 608,260

Income Taxes - Textual (Details

Income Taxes - Textual (Details) € in Millions, $ in Millions	3 Months Ended
	Jan. 30, 2021EUR (€)	Jan. 30, 2021USD ($)	Feb. 01, 2020
Income Tax Contingency [Line Items]
Federal statutory rate (as percent)	21.00%	21.00%	21.00%
Revenue Commissioners, Ireland
Income Tax Contingency [Line Items]
Tax settlement	€ 43	$ 52

Acquisitions - Textual (Details

Acquisitions - Textual (Details) $ in Millions	Feb. 12, 2021USD ($)	Sep. 30, 2020purportedShareholdernumberOfReportingUnit	Jan. 30, 2021USD ($)	Jul. 12, 2020USD ($)shares
Business Acquisition [Line Items]
Number of lawsuits | numberOfReportingUnit		3
Number of purported shareholders | purportedShareholder		2
Maxim
Business Acquisition [Line Items]
Conversion of company common stock (in shares) | shares				0.630
Termination fee, regulatory clearance				$ 830
Maxim | Subsequent event
Business Acquisition [Line Items]
Consideration transferred	$ 27,000
Maxim | Selling, marketing, general and administrative
Business Acquisition [Line Items]
Transaction costs			$ 15.2

Subsequent Events - Textual (De

Subsequent Events - Textual (Details) - Common Stock - Subsequent event $ / shares in Units, $ in Millions	Feb. 16, 2021USD ($)$ / shares
Subsequent Event [Line Items]
Common stock cash dividends per share, declared (in dollars per share) | $ / shares	$ 0.69
Dividends | $	$ 254.5